Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (4,007,317)	$ (1,800,359)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation expense	1,931,790	45,905
Loss on early payoff of note payable		174,412
Shares issued for services	5,573	398,674
Amortization of beneficial conversion feature		204,119
Amortization of financing costs		22,721
Depreciation	9,722
Amortization of future compensation payable	203,333
Interest expense	77,708	17,806
Changes in assets and liabilities:
Other receivable	57,445
Other long term assets		(255,893)
Inventory	(5,930)
Prepaids and deposits	5,433	(19,895)
Long term receivables - net	(141,182)
Accounts payable	(48,155)	158,353
Accrued expenses and compensation	(381,833)	(60,799)
Net cash used in operating activities	(2,293,413)	(1,114,956)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment	(4,410)	(38,887)
Net cash used in investing activities	(4,410)	(38,887)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from notes payable	2,150,000	149,750
Proceeds from issuance of common stock	150,000	1,690,000
Repayment on notes payable	(31,576)	(361,468)
Net cash provided by financing activities	2,268,424	1,478,282
Net increase (decrease) in cash and cash equivalents	(29,399)	324,439
Cash and cash equivalents, beginning of period	178,552	2,764
Cash and cash equivalents, end of period	149,153	327,203
Supplemental Cash Flow Information
Cash paid for interest	2,117	12,949
Cash paid for taxes
Schedule of Non-Cash Information
Discount on note payable on purchase of Applied Optical Sciences	2,500,000
Amortization of discount on note payable	(208,333)
Note payable on purchase of Applied Optical Sciences	$ (2,500,000)